Aaron Dominic Aguirre, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Optical Coherence | 29 | 2022 | 2957 | 1.670 |
Why?
|
Plaque, Atherosclerotic | 11 | 2022 | 1550 | 0.890 |
Why?
|
Shock | 1 | 2023 | 316 | 0.730 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 281 | 0.630 |
Why?
|
Optics and Photonics | 2 | 2017 | 307 | 0.580 |
Why?
|
Coronary Vessels | 9 | 2022 | 3124 | 0.490 |
Why?
|
Myocardial Infarction | 13 | 2025 | 11521 | 0.460 |
Why?
|
Heart Function Tests | 1 | 2014 | 317 | 0.440 |
Why?
|
Microscopy | 4 | 2014 | 909 | 0.390 |
Why?
|
Miniaturization | 3 | 2018 | 154 | 0.390 |
Why?
|
Heart | 5 | 2020 | 4448 | 0.380 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1292 | 0.380 |
Why?
|
Endoscopes | 2 | 2010 | 169 | 0.370 |
Why?
|
Microscopy, Confocal | 2 | 2010 | 1973 | 0.360 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1483 | 0.360 |
Why?
|
Intensive Care Units | 1 | 2023 | 3800 | 0.340 |
Why?
|
Interferon Regulatory Factor-3 | 2 | 2020 | 146 | 0.300 |
Why?
|
Peroxidase | 2 | 2023 | 610 | 0.300 |
Why?
|
Microscopy, Video | 2 | 2007 | 241 | 0.280 |
Why?
|
Equipment Design | 8 | 2018 | 3529 | 0.280 |
Why?
|
Myocytes, Cardiac | 2 | 2017 | 1682 | 0.270 |
Why?
|
Imaging, Three-Dimensional | 6 | 2017 | 4077 | 0.260 |
Why?
|
Myocardium | 4 | 2024 | 4790 | 0.260 |
Why?
|
Drug-Eluting Stents | 3 | 2017 | 681 | 0.260 |
Why?
|
Interferon Type I | 2 | 2020 | 569 | 0.240 |
Why?
|
Rupture, Spontaneous | 3 | 2021 | 365 | 0.240 |
Why?
|
Macrophages | 4 | 2020 | 5800 | 0.220 |
Why?
|
Coronary Artery Disease | 6 | 2022 | 6569 | 0.220 |
Why?
|
Gastrointestinal Tract | 1 | 2010 | 839 | 0.220 |
Why?
|
Computer Systems | 2 | 2015 | 470 | 0.220 |
Why?
|
Acute Coronary Syndrome | 5 | 2017 | 2194 | 0.210 |
Why?
|
Cells | 1 | 2003 | 166 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2017 | 3411 | 0.180 |
Why?
|
Copper Radioisotopes | 1 | 2020 | 100 | 0.170 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3538 | 0.170 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2022 | 266 | 0.170 |
Why?
|
Erythrocyte Indices | 1 | 2020 | 143 | 0.170 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2023 | 775 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 472 | 0.160 |
Why?
|
Dextrans | 1 | 2020 | 574 | 0.150 |
Why?
|
Perfusion | 1 | 2023 | 1402 | 0.150 |
Why?
|
Dioxygenases | 1 | 2020 | 352 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2226 | 0.150 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 379 | 0.150 |
Why?
|
Spectrophotometry | 1 | 2017 | 292 | 0.140 |
Why?
|
Atherosclerosis | 3 | 2022 | 3431 | 0.140 |
Why?
|
Telemetry | 1 | 2018 | 200 | 0.140 |
Why?
|
Electrocardiography | 3 | 2023 | 6413 | 0.140 |
Why?
|
Mice, Inbred C57BL | 11 | 2024 | 22381 | 0.140 |
Why?
|
Amiodarone | 1 | 2019 | 217 | 0.140 |
Why?
|
Neointima | 1 | 2017 | 133 | 0.140 |
Why?
|
Glucans | 1 | 2017 | 71 | 0.140 |
Why?
|
Image Enhancement | 5 | 2007 | 2898 | 0.130 |
Why?
|
Cardiac Surgical Procedures | 2 | 2022 | 3683 | 0.130 |
Why?
|
Breast Diseases | 2 | 2010 | 442 | 0.130 |
Why?
|
Polyglactin 910 | 1 | 2016 | 56 | 0.130 |
Why?
|
Collagen | 1 | 2024 | 2646 | 0.130 |
Why?
|
Regeneration | 1 | 2024 | 1524 | 0.120 |
Why?
|
Thoracic Surgery | 1 | 2021 | 729 | 0.120 |
Why?
|
Brain Mapping | 2 | 2008 | 6740 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2014 | 9081 | 0.120 |
Why?
|
Drug Carriers | 1 | 2019 | 710 | 0.110 |
Why?
|
Blood Platelets | 1 | 2025 | 2479 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 167 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2020 | 826 | 0.110 |
Why?
|
Barrett Esophagus | 2 | 2008 | 495 | 0.110 |
Why?
|
Molecular Probe Techniques | 1 | 2014 | 111 | 0.110 |
Why?
|
Atrial Fibrillation | 2 | 2022 | 5176 | 0.100 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 1468 | 0.100 |
Why?
|
Hemodynamics | 1 | 2023 | 4199 | 0.100 |
Why?
|
Pacemaker, Artificial | 1 | 2018 | 828 | 0.100 |
Why?
|
Zebrafish | 1 | 2024 | 3037 | 0.100 |
Why?
|
Angina, Unstable | 1 | 2016 | 893 | 0.100 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 313 | 0.100 |
Why?
|
Humans | 42 | 2025 | 768887 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 3253 | 0.100 |
Why?
|
Sirolimus | 2 | 2016 | 1540 | 0.100 |
Why?
|
Vascular System Injuries | 1 | 2015 | 248 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2017 | 1009 | 0.100 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2014 | 340 | 0.090 |
Why?
|
Neutrophils | 2 | 2021 | 3785 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2421 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1568 | 0.090 |
Why?
|
Platelet Count | 2 | 2025 | 787 | 0.090 |
Why?
|
Coronary Thrombosis | 1 | 2013 | 440 | 0.090 |
Why?
|
Mice | 13 | 2024 | 82074 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2734 | 0.090 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5834 | 0.090 |
Why?
|
Animals | 19 | 2024 | 169408 | 0.090 |
Why?
|
Bone Marrow | 1 | 2020 | 2935 | 0.090 |
Why?
|
Adenoma, Oxyphilic | 1 | 2011 | 152 | 0.090 |
Why?
|
Coronary Angiography | 6 | 2022 | 4541 | 0.090 |
Why?
|
Coronary Stenosis | 1 | 2016 | 802 | 0.080 |
Why?
|
Leukocyte Count | 2 | 2025 | 1609 | 0.080 |
Why?
|
Blood Pressure | 2 | 2023 | 8541 | 0.080 |
Why?
|
Critical Care | 1 | 2022 | 2715 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2542 | 0.080 |
Why?
|
Nanoparticles | 2 | 2020 | 1989 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2034 | 0.080 |
Why?
|
Algorithms | 5 | 2016 | 14199 | 0.080 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2020 | 113 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.080 |
Why?
|
Histocytochemistry | 1 | 2010 | 699 | 0.080 |
Why?
|
Colon | 2 | 2007 | 1804 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1904 | 0.070 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6673 | 0.070 |
Why?
|
Microscopy, Interference | 1 | 2007 | 35 | 0.070 |
Why?
|
Equipment Failure Analysis | 2 | 2006 | 848 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15471 | 0.070 |
Why?
|
Thyroid Diseases | 1 | 2010 | 385 | 0.070 |
Why?
|
Nonlinear Dynamics | 1 | 2008 | 494 | 0.070 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2139 | 0.070 |
Why?
|
Lipids | 1 | 2017 | 3345 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 1524 | 0.060 |
Why?
|
Intestine, Large | 1 | 2005 | 69 | 0.060 |
Why?
|
Leukocytes | 2 | 2025 | 2034 | 0.060 |
Why?
|
Artifacts | 1 | 2014 | 1942 | 0.060 |
Why?
|
Fibrosis | 3 | 2017 | 2081 | 0.060 |
Why?
|
Fluorine Radioisotopes | 2 | 2019 | 424 | 0.060 |
Why?
|
Organ Specificity | 1 | 2010 | 1970 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8745 | 0.060 |
Why?
|
Thrombolytic Therapy | 1 | 2013 | 2053 | 0.060 |
Why?
|
Calcinosis | 1 | 2013 | 1481 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2013 | 2080 | 0.060 |
Why?
|
Blood Cell Count | 1 | 2025 | 406 | 0.060 |
Why?
|
Female | 23 | 2025 | 397464 | 0.050 |
Why?
|
Male | 22 | 2025 | 365249 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9618 | 0.050 |
Why?
|
Reproducibility of Results | 9 | 2016 | 20244 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2010 | 1172 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
Stroke | 1 | 2025 | 9756 | 0.050 |
Why?
|
Rabbits | 2 | 2020 | 4774 | 0.050 |
Why?
|
Middle Aged | 17 | 2025 | 223740 | 0.050 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2010 | 957 | 0.050 |
Why?
|
Lung | 1 | 2020 | 10097 | 0.050 |
Why?
|
Esophagus | 1 | 2008 | 1043 | 0.050 |
Why?
|
Breast | 1 | 2010 | 1976 | 0.050 |
Why?
|
Inflammation | 4 | 2025 | 10869 | 0.050 |
Why?
|
Risk Assessment | 5 | 2022 | 24330 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2819 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18366 | 0.050 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2007 | 888 | 0.040 |
Why?
|
Time Factors | 6 | 2020 | 40266 | 0.040 |
Why?
|
Coronary Disease | 1 | 2015 | 5919 | 0.040 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2023 | 582 | 0.040 |
Why?
|
Heart Failure | 1 | 2025 | 11879 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10845 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2007 | 985 | 0.040 |
Why?
|
Xenopus laevis | 1 | 2003 | 966 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.040 |
Why?
|
Intestine, Small | 1 | 2005 | 1218 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1431 | 0.040 |
Why?
|
beta-Cyclodextrins | 1 | 2019 | 67 | 0.040 |
Why?
|
Aged | 12 | 2025 | 171790 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14485 | 0.040 |
Why?
|
Rats | 4 | 2008 | 23847 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2020 | 965 | 0.040 |
Why?
|
Ischemia | 1 | 2007 | 1900 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1379 | 0.040 |
Why?
|
Cicatrix | 1 | 2024 | 799 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2020 | 415 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.040 |
Why?
|
Photons | 1 | 2022 | 595 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3811 | 0.040 |
Why?
|
Hospitals | 2 | 2021 | 3903 | 0.040 |
Why?
|
Time | 1 | 2018 | 552 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3200 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 2360 | 0.030 |
Why?
|
Connexin 43 | 1 | 2017 | 202 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2024 | 1933 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 74971 | 0.030 |
Why?
|
Asia | 1 | 2017 | 629 | 0.030 |
Why?
|
Registries | 3 | 2017 | 8384 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 81892 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4300 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2299 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2013 | 13020 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15955 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 2016 | 367 | 0.030 |
Why?
|
DNA Ligases | 1 | 2014 | 81 | 0.030 |
Why?
|
Electrodes, Implanted | 1 | 2018 | 841 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8615 | 0.030 |
Why?
|
Recurrence | 2 | 2017 | 8512 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2194 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1369 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2041 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 796 | 0.030 |
Why?
|
Rupture | 1 | 2013 | 444 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7057 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2635 | 0.020 |
Why?
|
Aortic Valve | 1 | 2021 | 1969 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3438 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2663 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2603 | 0.020 |
Why?
|
Heart Atria | 1 | 2017 | 1360 | 0.020 |
Why?
|
Prognosis | 2 | 2025 | 30044 | 0.020 |
Why?
|
Thrombectomy | 1 | 2015 | 675 | 0.020 |
Why?
|
Microspheres | 1 | 2014 | 789 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5998 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3200 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1680 | 0.020 |
Why?
|
Software | 2 | 2018 | 4480 | 0.020 |
Why?
|
Skin | 1 | 2003 | 4507 | 0.020 |
Why?
|
Electrical Synapses | 1 | 2008 | 18 | 0.020 |
Why?
|
Adult | 8 | 2020 | 223818 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2163 | 0.020 |
Why?
|
Forelimb | 1 | 2008 | 116 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2126 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13677 | 0.020 |
Why?
|
Aluminum Oxide | 1 | 2007 | 41 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65485 | 0.020 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2007 | 45 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5890 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9375 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2016 | 1703 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2533 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 14751 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6546 | 0.020 |
Why?
|
Aorta | 1 | 2014 | 2046 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2008 | 398 | 0.020 |
Why?
|
Incidence | 2 | 2015 | 21545 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12563 | 0.020 |
Why?
|
Colonoscopes | 1 | 2004 | 17 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39394 | 0.010 |
Why?
|
Titanium | 1 | 2007 | 495 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59738 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10778 | 0.010 |
Why?
|
Aspirin | 1 | 2015 | 3135 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2763 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2297 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 1093 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21187 | 0.010 |
Why?
|
Lasers | 1 | 2007 | 952 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2007 | 1890 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7453 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 54950 | 0.010 |
Why?
|
Video Recording | 1 | 2007 | 976 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19023 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8095 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3840 | 0.010 |
Why?
|
Brain | 1 | 2008 | 27476 | 0.010 |
Why?
|
Thrombosis | 1 | 2015 | 2956 | 0.010 |
Why?
|
Echocardiography | 1 | 2014 | 5046 | 0.010 |
Why?
|
Motion | 1 | 2004 | 794 | 0.010 |
Why?
|
Anticoagulants | 1 | 2015 | 4850 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5323 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15875 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16735 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 8200 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 1674 | 0.010 |
Why?
|
Young Adult | 2 | 2015 | 60110 | 0.010 |
Why?
|
Colonoscopy | 1 | 2004 | 1410 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22294 | 0.010 |
Why?
|
Endoscopy | 1 | 2004 | 1862 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6401 | 0.010 |
Why?
|